Industry perspectives on prenatal genetic testing

Amy Leigh Swanson*, James D. Goldberg

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Until recent years, prenatal genetic tests have been almost exclusively developed and implemented by academic physicians and laboratories. In the last several years, industry has led the development of novel prenatal genetic tests, funded clinical trials and implemented these tests into clinical practice. That these efforts have been driven by industry has raised questions about diagnostics development regulations, consistency in reporting of results, and management of potential conflicts of interest. In this article, these topics are addressed from an industry perspective. While commercial laboratories may have the resources to develop and offer novel genetic tests, collaboration with healthcare providers is crucial for appropriate, effective, and efficient utilization of such tests.

Original languageEnglish (US)
Pages (from-to)314-317
Number of pages4
JournalSeminars in Perinatology
Issue number5
StatePublished - Aug 2018


  • Commercial laboratories
  • Diagnostics
  • Diagnostics development
  • Industry
  • Prenatal genetic tests

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Industry perspectives on prenatal genetic testing'. Together they form a unique fingerprint.

Cite this